<DOC>
	<DOCNO>NCT02624479</DOCNO>
	<brief_summary>Chronic treatment prophylaxis vessel soft tissue calcification well renal calculus could future indication sodium thiosulfate ( STS ) . Using oral formulation might increase compliance treatment success compare parenteral administration . Three gastro-resistant formulation STS oral administration develop different release characteristic : fast-release , medium-release slow-release tablet . Aim enteric coat increase oral bioavailability STS . The bioavailability tolerability formulation oral administration healthy volunteer compare clinical trial .</brief_summary>
	<brief_title>Pharmacokinetic Study Investigate Bioavailability Tolerability 3 Oral Formulations Sodium Thiosulfate</brief_title>
	<detailed_description />
	<mesh_term>Sodium thiosulfate</mesh_term>
	<criteria>Male female healthy subject â‰¥ 18 year Negative pregnancy test female subject childbearing age Able understand character individual consequence clinical trial provide write informed consent participate study Pregnant lactating subject . Renal impairment ( creatinine clearance &lt; 60ml/min ) Concomitant medication Gastrointestinal diseases History alcohol abuse , illicit drug use , significant mental illness , physical dependance opioid , drug abuse addiction ( last 12 month )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Pharmacokinetics</keyword>
</DOC>